DeepIntent develops advertising technologies tailored to the healthcare sector. Its platform helps pharmaceutical companies and their agencies raise awareness of their treatments by precisely targeting the right doctors and patients. For example, a campaign can be targeted exclusively at cardiologists likely to prescribe a medication, or at patients affected by a specific condition, rather than reaching a broad audience without knowing whether they are relevant to the treatment in question. The U.S.-based company offers a wide range of advertising channels, from the Disney+ platform to Spotify podcasts and television commercials during major events like the Super Bowl.
DeepIntent centralizes every stage of a campaign, from planning to measuring results, using real-time data to adjust the actions to be taken. The U.S.-based company currently works with more than 600 pharmaceutical brands, including major groups such as Novartis, GSK, and AstraZeneca, as well as more than 10 of the world’s leading pharmaceutical companies. Its unique feature is the combination of real-world medical data and digital tools to make communication targeted and useful, within a framework that adheres to very strict confidentiality rules. The stated goal is to go beyond traditional advertising by helping to better inform patients and physicians, and ultimately, to improve patient care pathways.
Helix, DeepIntent’s new solution, serves as a comprehensive technological foundation for healthcare marketing. It is a new environment where companies can build their own solutions using a vast amount of ready-to-use data. The platform provides access to information on more than 3.7 million healthcare professionals and over 240 million patients, all within a secure framework that complies with industry regulations.
The main benefit of Helix is that it brings together in a single system data that is typically scattered across multiple tools. What’s new is the combination of a laboratory’s own data with comprehensive medical data and campaign results. Helix then makes it possible to identify precisely which doctors can prescribe a treatment, which patients are affected, and to tailor actions accordingly.
Instead of having to build costly systems to manage sensitive data, Helix provides businesses with a ready-to-use infrastructure, which significantly speeds up the launch of marketing campaigns. Early results show that campaigns are launched up to 50% faster, with significant gains in engagement and an increase in referrals.
Finally, Helix directly integrates artificial intelligence to analyze data and generate actionable insights, enabling a faster transition from idea to action. More broadly, Helix addresses a structural challenge in the industry: finally making vast amounts of complex and sensitive data usable so that it can be transformed into concrete decisions.
